Shiraishi Hiroaki, Mikami Tetuo, Yoshida Tsutomu, Tanabe Satoshi, Kobayashi Nobuyuki, Watanabe Masahiko, Okayasu Isao
Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara 228-8555, Japan.
J Gastroenterol. 2006 Dec;41(12):1186-96. doi: 10.1007/s00535-006-1953-4. Epub 2007 Feb 6.
We have shown previously that stromal genetic alteration may make a greater contribution to early genesis of ulcerative colitis-associated tumors than sporadic colon cancers. We assessed whether similar differences in genetic alteration might exist between squamous cell carcinomas (SCCs) and Barrett's adenocarcinomas (BACs) of the esophagus.
We investigated epithelial and stromal genetic instability with five National Cancer Institute standard (NCI), four chromosome 17 (Chr. 17), and six tumor suppressor gene (TSG) microsatellite markers in 26 SCC and 12 BAC cases and in 11 normal controls, using a novel combination of microdissection, polymerase chain reaction, and GeneScan.
Frequency of epithelial loss of heterozygosity (LOH) increased in the order background mucosa, to precursor lesions, to tumors with both types of carcinoma, especially for the Chr. 17 and TSG markers, while stromal LOH was relatively high but consistent from background mucosa to carcinoma. Epithelial LOH of D17S796 demonstrated a significantly higher frequency in SCCs than in BACs, without significant variation in p53 overexpression. The frequency of microsatellite instability (MSI) showed constant high levels in both epithelium and stroma of background, dysplasia, and carcinomas in the SCC series, and rather low frequencies in the BAC series. Although epithelial hMLH1 and hMSH2 expression decreased with tumor progression, no correlation was found with the individual MSI status.
Although epithelial LOH exists similarly in both lesion types, whereas epithelial and stromal MSI may occur in a relatively early phase of SCC development, stromal MSI is rare in BACs, strongly suggesting differences in tumorigenesis between the two types.
我们之前已经表明,与散发性结肠癌相比,基质基因改变可能对溃疡性结肠炎相关肿瘤的早期发生起更大作用。我们评估了食管鳞状细胞癌(SCC)和巴雷特腺癌(BAC)之间在基因改变方面是否可能存在类似差异。
我们使用显微切割、聚合酶链反应和基因扫描的新组合,用五个美国国立癌症研究所标准(NCI)、四个17号染色体(Chr. 17)和六个肿瘤抑制基因(TSG)微卫星标记,对26例SCC和12例BAC病例以及11例正常对照进行上皮和基质基因不稳定性研究。
杂合性缺失(LOH)的上皮频率按背景黏膜、前体病变、两种类型癌的肿瘤顺序增加,尤其是对于Chr. 17和TSG标记,而基质LOH相对较高,但从背景黏膜到癌是一致的。D17S796的上皮LOH在SCC中的频率显著高于BAC,p53过表达无显著差异。微卫星不稳定性(MSI)频率在SCC系列的背景、发育异常和癌的上皮和基质中均持续高水平,而在BAC系列中频率较低。尽管上皮hMLH1和hMSH2表达随肿瘤进展而降低,但与个体MSI状态无相关性。
尽管两种病变类型中上皮LOH类似存在,上皮和基质MSI可能在SCC发生的相对早期阶段出现,但基质MSI在BAC中罕见,强烈提示两种类型肿瘤发生存在差异。